One-year cost of Ribociclib

Ribociclib/Calilon (Ribociclib) is a selective CDK4/6 inhibitor, mainly used for patients with hormone receptor-positive (HR+), HER2 -negative advanced or metastatic breast cancer . The standard recommended dose is 600mg once a day, usually taken through three 200mg film-coated tablets, for 21 days and then discontinued for 7 days to form a complete 28 day treatment cycle. The common tablet specifications are 200mg*63 tablets per box, and the price of domestic original drugs is usually around RMB 4,000. Calculated based on the standard treatment cycle and recommended dosage, a patient needs about 13 boxes of medicine per year, so the total cost may reach more than 50,000 yuan. The specific cost will vary depending on regional pharmacy prices, medical insurance reimbursement ratios, and individual out-of-pocket expenses.

There are also options for generic drugs in overseas markets. For example, 200mg*21 tablets produced in Laos may be sold for more than 1,000 yuan per box. Exchange rate changes and supply channels may cause actual costs to fluctuate. For some patients with limited economic conditions, generic drugs provide a treatment option with controllable prices and clinical efficacy close to that of the original drugs. In clinical practice, doctors will rationally arrange drug sources and purchase channels based on the patient's condition, drug resistance risk and economic status.

In addition to drug costs, Riboxil treatment also involves additional expenses such as follow-up examinations, laboratory tests and adverse reaction monitoring, especially hematology and liver function monitoring, which are also key points of treatment management that are particularly emphasized in overseas guidelines. Patients should fully understand the total annual cost and long-term financial affordability before initiating treatment to ensure compliance and safety of continuous treatment. Through medical insurance, pharmaceutical company assistance programs or local subsidies, patients can reduce financial pressure while ensuring the smooth completion of high-quality treatment.

Reference: https://us.kisqali.com/